James Moore's profile photo

James Moore

Featured in: Favicon whatnext.com

Articles

  • Dec 20, 2024 | whatnext.com | James Moore

    PART V: MOVING FORWARDContinued from Part FourAfter about three months on the new treatment, I was scheduled for more scans. I knew the tumor had shrunk as the esophagus had returned to its normal position (it previously had been bent to the side), and the swelling had gone down to virtually nothing. The scans came back showing no cancer in my body! That afternoon as I sat in my car in front of the school where I was teaching, I couldn’t get a hold of any of my girls, so I called my mother-in-law.

  • Dec 18, 2024 | whatnext.com | James Moore

    PART III: SUPPORT SYSTEM AND PLOT TWIST!Continued from Part TwoAs previously mentioned, my wife is my main support. She has gone with me to every appointment and did so for three years until COVID hit. She was most helpful in just being there taking notes and helping me to remember what to do, when to do it, and verifying that what I thought I heard and understood was actually what was happening and said.

  • Dec 17, 2024 | whatnext.com | James Moore

    PART II: COPING WITH A NEW REALITYContinued from Part OneSo now I have a prognosis, and I realize I am in deep trouble; however, before I leave the hospital for the long drive home, I was set up with a bunch of appointments for scans and lab work to be done in my home area. The facility was part of a statewide organization of imagining and medical centers, so that part of the process was pretty seamless.

  • Dec 16, 2024 | whatnext.com | James Moore

    In 2016, I was diagnosed with stage 4 head and neck squamous carcinoma and later stage 2 colon cancer. As far as symptoms, there really weren’t any. I had a bad sinus infection about a year earlier and had swelling in the glands on the left side of my neck. My local doctor had put me on antibiotics. I had some soreness and vividly remember hugging my oldest daughter as she was leaving after a visit, and she laid her head on my right shoulder and pressed against the lump on my neck.

  • Dec 13, 2024 | whatnext.com | James Moore

    According to a press release in Business Wire, the results of a recent clinical trial produced promising outcomes in the treatment of multiple myeloma, a rare cancer. This trial evaluated belantamab mafodotin in multiple myeloma and compared it to a combination treatment based on daratumumab. The treatment produced an enhanced overall survival benefit and a reduced risk of death.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →